Guideline
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - European Hematology Association (EHA) and European Society for Medical Oncology (ESMO)
These Guidelines were developed by the European Hematology Association (EHA) and ESMO. The two societies nominated authors to write the guidelines as well as reviewers to comment on them.
These EHA-ESMO Clinical Practice Guidelines provide key recommendations on the management of multiple myeloma.
Key treatment recommendations are provided for both newly diagnosed myeloma patients and patients with relapsed/refractory disease.
Recommendations for the treatment of plasma cell leukaemia, solitary plasmacytoma and smouldering myeloma are also provided .
Key recommendations for myeloma complications, including bone disease and renal impairment, are included.